Hemp farmers searching for flower-storage solutions
(Photo courtesy of Hemptown) (This is an abridged version of a story that appears in the July issue of Marijuana Business Magazine. On Wednesday, read about strategies for storing hemp fiber and grain.) Storing hemp properly is arguably as important as planting, harvesting or any other step in the cultivation... Read more
Member Blog: The Power Of Numbers
by Kary Radestock, Hippo Premium Packaging This month, the cannabis industry gathers in San Jose for the NCIA’s 6th Annual Cannabis Business Summit & Expo. It is projected that nearly 10,000 people will attend.  Think about that number for a minute. Ten thousand. Just a handful of years ago,... Read more
Here’s final chance to tell FDA how it should regulate CBD
U.S. health authorities are taking final comments from the public on how to regulate over-the-counter cannabis extracts such as CBD. The suggestions are due to the U.S. Food and Drug Administration (FDA) by midnight ET Tuesday on how the agency should regulate cannabis-derived products. The FDA has vowed to expedite its... Read more
CBD company ups stake in beverage brand to secure 50-state distribution
A Toronto-based hemp and CBD investment company increased its stake in a traditional soda company with an eye toward developing CBD-infused beverages with the brand. HeavenlyRx bought 15 million shares in Jones Soda Co. for $9 million and now holds 39% of the Seattle-based beverage manufacturer. The deal also gives HeavenlyRx two... Read more
What is hemp? Industry members debate which cultivars fit federal definition
As the hemp industry waits for the U.S. Department of Agriculture (USDA) to finish its federal hemp production rules in time for the 2020 season, hemp companies are speculating whether the agency will further define which varieties and cultivars will be allowed to be used under the 2018 Farm... Read more
Investment firm increases stake in CBD company
Sol Global, a Toronto-based international cannabis investment firm, has increased its stake in a privately held CBD company. The firm announced Friday it spent $11.5 million (15 million Canadian dollars) in HeavenlyRx. The purchase brings Sol Global to a 42% stake in HeavenlyRx. The announcement comes less than a... Read more
FDA to provide update on CBD review by late summer or fall, official says
Federal health regulators say they’ll update the hemp industry on their CBD review by late summer or fall. Dr. Amy Abernethy, who leads the U.S. Food and Drug Administration’s work group on cannabinoids such as CBD, said Friday the agency is “enthusiastic about research into the therapeutic benefits of CBD... Read more
Ten Reasons To Join Us At #CannaBizSummit In Ten Days
The 6th Annual Cannabis Business Summit & Expo begins in TEN DAYS! So we’re bringing you TEN reasons why you should make plans to join us: Your Registration Dollars are Put to WorkMost industry events are out to make a buck. But when you attend one of NCIA’s business... Read more
Demetrix raises $50 million to research synthetic cannabinoid production
California-based Demetrix secured $50 million in a Series A funding, which the company will use for research of synthetic cannabinoid production. The Emeryville company wants to use baker’s yeast to produce large volumes of cannabinoids. More than 100 of cannabinoids can be found in the cannabis plant, sometimes in... Read more
Re-Cap of House Judiciary Hearing on Marijuana Laws in America
On Wednesday, for the first time ever, lawmakers in the House of Representatives held a hearing to address the disproportionate ways in which marijuana prohibition has negatively impacted people of color and marginalized communities. The hearing, entitled “Marijuana Laws in America: Racial Justice and the Need for Reform,” was... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )